List of insiders holdings for ENDOLOGIX INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | ELLIOTT INTERNATIONAL L.P. 10% Owner |
2010-12-16 16:20:31 | 3,318,002 0 |
3,318,002 | Form 4 |
2 | ESSEX WOODLANDS HEALTH VENTURES FUND VII LP 10% Owner |
2016-02-12 12:48:30 | 1,257,468 0 |
1,257,468 | Form 13G |
3 | ELLIOTT ASSOCIATES L.P. 10% Owner |
2011-08-15 15:09:31 | 969,399 0 |
969,399 | Form 13D |
4 | McDermott John D Director |
2018-05-30 18:51:41 | 879,423 0 |
879,423 | Form 4 |
5 | Chavez Christopher G. Director |
2018-05-30 19:39:15 | 378,346 0 |
378,346 | Form 4 |
6 | Mitchell Robert D President |
2017-06-20 10:50:38 | 316,886 0 |
316,886 | Form 4 |
7 | BUCHBINDER MAURICE Director |
2004-10-25 17:33:48 | 298,294 0 |
298,294 | Form 4 |
8 | HENSON MICHAEL R Director |
2003-11-18 16:19:56 | 0 209,095 |
209,095 | Form 4 |
9 | Chobotov Michael V. Chief Technology Officer |
2016-09-26 11:03:40 | 203,269 0 |
203,269 | Form 4/A |
10 | BISHOP JOSEPH A Vice President Research & Devl |
2003-12-12 18:10:06 | 180,000 0 |
180,000 | Form 4 |
11 | UYESUGI KAREN Vice President |
2007-10-30 20:03:14 | 166,900 0 |
166,900 | Form 4 |
12 | Onopchenko John CEO and Director |
2020-08-14 19:57:00 | 165,698 0 |
165,698 | Form 4 |
13 | O'Quinn Shari L VP, Clinical & Regulatory |
2017-06-06 09:55:26 | 159,356 0 |
159,356 | Form 4 |
14 | DeJohn Joseph A. General Manager, Asia & Pac |
2016-07-11 10:54:48 | 153,471 0 |
153,471 | Form 4 |
15 | Krist Robert John Chief Financial Officer |
2012-12-31 13:10:19 | 142,236 0 |
142,236 | Form 4 |
16 | SCHRECK STEFAN Vice President |
2013-10-15 20:37:23 | 140,136 0 |
140,136 | Form 4 |
17 | Hawkins Daniel Vice Pres - Global Marketing |
2009-04-14 18:41:59 | 125,000 0 |
125,000 | Form 4 |
18 | Mahboob Vaseem Chief Financial Officer |
2020-03-26 16:36:18 | 111,716 0 |
111,716 | Form 4 |
19 | Kiernan Jane E Director |
2020-03-18 16:32:31 | 103,847 0 |
103,847 | Form 4 |
20 | Fauls Janet Mary VP Regulatory Affairs |
2015-06-01 10:28:50 | 101,346 0 |
101,346 | Form 4 |
21 | BROWN FRANKLIN D Director |
2011-11-04 17:35:24 | 94,700 0 |
94,700 | Form 4 |
22 | Abraham Todd VP of Operations |
2015-11-17 11:15:47 | 86,821 0 |
86,821 | Form 4 |
23 | Ferracci Cecile General Manager, Europe |
2016-02-17 16:18:11 | 81,286 0 |
81,286 | Form 4 |
24 | Lima Jose A. VP-Quality |
2016-08-22 16:28:20 | 70,855 0 |
70,855 | Form 4 |
25 | Mertens Herbert H Vice President of Sales/Mktg |
2005-02-25 19:30:10 | 70,000 0 |
70,000 | Form 4 |
26 | Thunen Shelley B Named Executive Officer |
2015-10-21 14:42:28 | 53,995 0 |
53,995 | Form 4 |
27 | Thompson Matthew Chief Medical Officer |
2020-08-14 18:47:44 | 52,878 0 |
52,878 | Form 4 |
28 | THIEL JEFFREY H Director |
2004-01-06 18:29:28 | 0 51,192 |
51,192 | Form 4/A |
29 | Jennings David M. VP-Human Resources |
2016-06-02 16:00:05 | 50,281 0 |
50,281 | Form 4 |
30 | Nagel Laura VP, Quality |
2018-03-15 16:23:44 | 48,860 0 |
48,860 | Form 4 |
31 | Love Charles Steele VP-Clinical Affairs |
2016-01-28 13:30:58 | 45,037 0 |
45,037 | Form 4 |
32 | Zenty III Thomas F Director |
2019-08-06 17:28:30 | 44,570 0 |
44,570 | Form 4 |
33 | DePalma Amanda L. VP, Global Marketing |
2016-06-02 15:59:49 | 43,772 0 |
43,772 | Form 4 |
34 | NEELS GUIDO J Director |
2019-04-03 16:09:22 | 43,200 0 |
43,200 | Form 4 |
35 | Zehren John Chief Commercial Officer |
2020-01-09 21:21:43 | 40,138 0 |
40,138 | Form 4 |
36 | Sorsher Gary I. Vice President - Quality |
2013-10-01 14:45:32 | 40,120 0 |
40,120 | Form 4 |
37 | DIETHRICH EDWARD Director |
2008-05-23 16:59:21 | 40,000 0 |
40,000 | Form 4 |
38 | Norwalk Leslie V Director |
2019-08-06 17:16:59 | 38,955 0 |
38,955 | Form 4 |
39 | Machek James Edward VP-Research & Development |
2016-06-02 16:02:01 | 38,286 0 |
38,286 | Form 4 |
40 | HAYDEN JEREMY B. General Counsel |
2019-10-07 18:35:51 | 32,040 0 |
32,040 | Form 4 |
41 | RICHARDS DAVID M Chief Financial Officer & Secr |
2004-08-03 15:10:24 | 30,546 0 |
30,546 | Form 4 |
42 | Greenstein Leonard M. VP Finance & Corp Controller |
2013-10-04 11:58:59 | 28,518 0 |
28,518 | Form 4 |
43 | Lyons Ruth Anne VP Global Marketing |
2014-03-18 12:13:49 | 27,168 0 |
27,168 | Form 4 |
44 | Fecho Jeff Chief Quality Officer |
2020-08-07 20:19:50 | 23,732 0 |
23,732 | Form 4 |
45 | ODONNELL JEFFREY F Director |
2010-05-24 14:11:41 | 20,000 0 |
20,000 | Form 4 |
46 | Coelyn Ronald H Director |
2007-05-23 18:56:44 | 20,000 0 |
20,000 | Form 4 |
47 | Tyler Martin VP, International |
2013-03-15 18:29:19 | 14,472 0 |
14,472 | Form 4 |
48 | DE GREEF RODERICK Director |
2013-03-08 18:25:37 | 7,102 0 |
7,102 | Form 4 |
49 | Pinto Cynthia Buch Interim CFO |
2020-08-14 18:04:04 | 6,304 0 |
6,304 | Form 4 |
50 | Brady Timothy Nicholas Controller and Corp Secretary |
2020-08-14 18:51:10 | 891 0 |
891 | Form 4 |
51 | WALLER GREGORY D Director |
2020-08-14 20:04:11 | 710 0 |
710 | Form 4 |
52 | MCCORMICK PAUL Director |
2010-05-03 19:50:31 | 332.69 0 |
332.69 | Form 4 |
53 | Camber Capital Management LP 10% Owner |
2020-02-14 09:35:10 | 0 0 |
0 | Form 13G |
54 | MOTT RICHARD W Director |
2020-07-07 21:09:30 | 0 0 |
0 | Form 3 |
55 | Wilder Thomas Director |
2020-08-14 18:49:02 | 0 0 |
0 | Form 4 |
56 | Lemaitre Dan Director |
2020-09-17 16:35:50 | 0 0 |
0 | Form 4 |